Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2007 1
2008 1
2009 5
2010 6
2011 6
2012 3
2014 1
2015 10
2016 22
2017 11
2018 12
2019 13
2020 11
2021 2
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

85 results
Results by year
Filters applied: . Clear all
Page 1
Glutamate dehydrogenase (GLUD1) expression in breast cancer.
Craze ML, El-Ansari R, Aleskandarany MA, Cheng KW, Alfarsi L, Masisi B, Diez-Rodriguez M, Nolan CC, Ellis IO, Rakha EA, Green AR. Craze ML, et al. Among authors: aleskandarany ma. Breast Cancer Res Treat. 2019 Feb;174(1):79-91. doi: 10.1007/s10549-018-5060-z. Epub 2018 Nov 23. Breast Cancer Res Treat. 2019. PMID: 30470977
A novel prognostic two-gene signature for triple negative breast cancer.
Alsaleem MA, Ball G, Toss MS, Raafat S, Aleskandarany M, Joseph C, Ogden A, Bhattarai S, Rida PCG, Khani F, Davis M, Elemento O, Aneja R, Ellis IO, Green A, Mongan NP, Rakha E. Alsaleem MA, et al. Among authors: aleskandarany m. Mod Pathol. 2020 Nov;33(11):2208-2220. doi: 10.1038/s41379-020-0563-7. Epub 2020 May 13. Mod Pathol. 2020. PMID: 32404959
Prognostic significance of nucleolar assessment in invasive breast cancer.
Elsharawy KA, Toss MS, Raafat S, Ball G, Green AR, Aleskandarany MA, Dalton LW, Rakha EA. Elsharawy KA, et al. Among authors: aleskandarany ma. Histopathology. 2020 Apr;76(5):671-684. doi: 10.1111/his.14036. Epub 2020 Mar 26. Histopathology. 2020. PMID: 31736094
85 results